Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06946563 · ClinicalTrials.gov registry record
Fetoscopic Neural Tube Defect Repair
A clinical trial of Spina Bifida and Neural Tube Defects, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT06946563: Recruiting study of Spina Bifida and Neural Tube Defects, sponsored by Oregon Health and Science University.
NCT06946563 is a study of Spina Bifida and Neural Tube Defects that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 25 participants, below the 51-participant average among 16 other Spina Bifida trials with a reported enrollment target (51% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06946563, a study of Spina Bifida and Neural Tube Defects, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-arm prospective study to record maternal and neonatal outcomes on subjects who undergo fetoscopic repair of Neural Tube Defects (NTD) at Oregon Health \& Science University (OHSU). Fetoscopic repair will take place between 24 weeks 0 days and 27 weeks 6 days gestation. Surgical, post-operative, delivery, and neonatal outcomes will be collected.
Primary Outcome
Whether closure was achieved and whether the case was completed using the fetoscopic technique
Conditions Studied
Interventions
- DEVICE Fetoscopic Neural Tube Defect Repair Devices
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2033-04 |
What NCT06946563 shows while recruiting
NCT06946563 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 51-participant average among 16 other Spina Bifida trials with a reported enrollment target (51% lower).
The record links to 2 conditions, with Spina Bifida appearing as the primary indexed condition, and to 1 intervention - of which Fetoscopic Neural Tube Defect Repair Devices is the first listed.
NCT06946563 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT06946563 about?
NCT06946563 is a clinical study titled "Fetoscopic Neural Tube Defect Repair". This is a single-arm prospective study to record maternal and neonatal outcomes on subjects who undergo fetoscopic repair of Neural Tube Defects (NTD) at Oregon Health \& Science University (OHSU). Fetoscopic repair will take place between 24 weeks 0 days and 27 weeks 6 days gestation. Surgical, pos...
What is the current status of trial NCT06946563?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2023-04-01. Estimated completion is 2033-04.
What conditions does trial NCT06946563 study?
This clinical trial studies the following conditions: Spina Bifida, Neural Tube Defects.
What interventions are being tested in trial NCT06946563?
The interventions under investigation include: Fetoscopic Neural Tube Defect Repair Devices (DEVICE).
Who is sponsoring clinical trial NCT06946563?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06946563 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spina Bifida
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06946563's enrollment target sits among peer trials
25 10th of 16 higher than 7 of 16 other Spina Bifida trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spina Bifida trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating Long-term Use of a Pediatric Robotic Exoskeleton (P.REX/Agilik) to Improve Gait in Children With Movement Disorders
RECRUITING · NA
-
Transcutaneous Tibial Nerve Stimulation (TTNS) Treatment in Spina Bifida Pediatric Patients With Neurogenic Bladder
RECRUITING · NA
-
Laparotomy Versus Percutaneous Endoscopic Correction of Myelomeningocele
RECRUITING · NA
-
Autologous Human Umbilical Cord Tissue Patch for Postnatal Closure of Open Neural Tube Defects
RECRUITING · NA
-
Transcutaneous Spinal Stimulation for Children and Youth With Spina Bifida
RECRUITING · NA
-
Mobile Health Self-Management and Support System for Chronic and Complex Health Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI